Cargando…
Comment on ‘Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)'
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817324/ https://www.ncbi.nlm.nih.gov/pubmed/24064973 http://dx.doi.org/10.1038/bjc.2013.581 |
| _version_ | 1782478055903592448 |
|---|---|
| author | Nagano, H |
| author_facet | Nagano, H |
| author_sort | Nagano, H |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3817324 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-38173242013-11-06 Comment on ‘Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)' Nagano, H Br J Cancer Letter to the Editor Nature Publishing Group 2013-10-29 2013-09-24 /pmc/articles/PMC3817324/ /pubmed/24064973 http://dx.doi.org/10.1038/bjc.2013.581 Text en Copyright © 2013 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ |
| spellingShingle | Letter to the Editor Nagano, H Comment on ‘Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)' |
| title | Comment on ‘Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)' |
| title_full | Comment on ‘Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)' |
| title_fullStr | Comment on ‘Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)' |
| title_full_unstemmed | Comment on ‘Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)' |
| title_short | Comment on ‘Phase III randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages IB2, IIA2, and IIB cervical cancer: a Japan Clinical Oncology Group trial (JCOG 0102)' |
| title_sort | comment on ‘phase iii randomised controlled trial of neoadjuvant chemotherapy plus radical surgery vs radical surgery alone for stages ib2, iia2, and iib cervical cancer: a japan clinical oncology group trial (jcog 0102)' |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817324/ https://www.ncbi.nlm.nih.gov/pubmed/24064973 http://dx.doi.org/10.1038/bjc.2013.581 |
| work_keys_str_mv | AT naganoh commentonphaseiiirandomisedcontrolledtrialofneoadjuvantchemotherapyplusradicalsurgeryvsradicalsurgeryaloneforstagesib2iia2andiibcervicalcancerajapanclinicaloncologygrouptrialjcog0102 |